ライフサイエンスコーパス: intubation

1 %] were intubated and nine died [3%] without intubation).

2 heral oxygen saturation reading < 80% during intubation).

3 or determining HFNC outcome (need or not for intubation).

4 m 66 subsequently died, and 166 died without intubation).

5 , continuous positive airway pressure and/or intubation).

6 e ventilation within 6 hours before tracheal intubation.

7 eau pressure <= 30 cm H2O) within 3 hours of intubation.

8 th a successful first attempt at orotracheal intubation.

9 d severe oxygen desaturation during tracheal intubation.

10 redictive of risk for hospital admission and intubation.

11 h, and chest CT performed within 24 hours of intubation.

12 ere 434 deaths and 27 patients who underwent intubation.

13 n and prevent VAP occurrence during tracheal intubation.

14 en desaturation compared to primary tracheal intubation.

15 tilation, or ICU length of stay by timing of intubation.

16 nd pulse oximetry values during endotracheal intubation.

17 ng to the rectosigmoid junction was noted at intubation.

18 to patients if performed after 2 weeks from intubation.

19 inical finding reliably excludes a difficult intubation.

20 tients with low and those with high risk for intubation.

21 onsistently associated with a lower risk for intubation.

22 n the validation cohort, 68 (35.6%) required intubation.

23 lt patients needing out-of-hospital tracheal intubation.

24 on serious adverse event during endotracheal intubation.

25 ypoxemic respiratory failure is to not delay intubation.

26 tween induction and 2 minutes after tracheal intubation.

27 ts with marked hypoxemia before endotracheal intubation.

28 g fluids were collected for 7 days following intubation.

29 Laryngoscopy following endotracheal intubation.

30 rdiac arrest or death within 1 h of tracheal intubation.

31 rtion of patients with successful first-pass intubation.

32 quiring general anesthesia with endotracheal intubation.

33 and death during or soon after endotracheal intubation.

34 otulism can include preparation for possible intubation.

35 d owing to emergent pre-endovascular therapy intubation.

36 andidate bacteria by oral gauge intragastric intubation.

37 ght patients (88%) were alive 24 hours after intubation.

38 gh-sensitivity troponin I within 24 hours of intubation.

39 a including 4 deaths and 1 tooth loss during intubation.

40 ly exposed to noninvasive ventilation before intubation.

41 was noted in 74 (37.6%) patients, requiring intubation.

42 ose who died had advanced directives against intubation.

43 rasound examination performed at the time of intubation.

44 one in 10 PICU patients undergoing tracheal intubation.

45 12% required non-rebreather and 35% required intubation.

46 or numbness, diplopia, and tooth loss during intubation.

47 ventilation in the 6 hours prior to tracheal intubation.

48 enable to identify patients at high risk for intubation.

49 to the intensive care unit, and 13 requiring intubation.

50 We enrolled 202 consecutive endotracheal intubations.

51 eus (5.9% vs 14.2%, P < 0.01), and unplanned intubation (0% vs 2.3%, P = 0.02).

52 s (24/76, 32%) than in first-attempt success intubations (14/126, 11%) (p < 0.001).

53 Rates of ventilation (20-33%), intubation (15-24%), and dialysis (3-5%) varied accordin

54 red more frequently in first-attempt failure intubations (24/76, 32%) than in first-attempt success i

55 e associated with lower risk of endotracheal intubation (25 studies [3804 patients]).

56 re Assessment for the first 7 days following intubation, 3) the highest Sequential Organ Failure Asse

57 intensive care unit admission (35% vs 36%), intubation (33% vs 25%), and mortality (37% vs 32%).

58 tracheal intubation encounters; 424 tracheal intubations (44%) occurred after noninvasive ventilation

59 166 patients; SOE, low), and lower need for intubation (5.34% vs 14.71%; RD, -8.02% [95% CI, -14.77%

60 0-20.0], P=0.001), led to fewer endotracheal intubations (52% versus 85%, P<0.001), and had overall w

61 ates of intensive care unit admission (69%), intubation (65%), renal replacement therapy (RRT; 33%),

62 50; 95% CI: 0.45 to 0.57, respectively), and intubation (aHR: 0.69; 95% CI: 0.51 to 0.94 and aHR: 0.7

63 nylcholine are often used for rapid sequence intubation, although the comparative efficacy of these p

64 AC was associated with lower mortality and intubation among hospitalized COVID-19 patients.

65 dary outcomes included the need for tracheal intubation (among patients not intubated at baseline); c

66 uced an AUC of 0.64 (95% CI: 0.55, 0.73) for intubation and an AUC of 0.59 (95% CI: 0.50, 0.68) for d

67 es were similar between the groups on day of intubation and day of ultrasound (p = 0.44 and p = 0.07,

68 and clinical variables increased the AUC of intubation and death to 0.88 (95% CI: 0.79, 0.96) and 0.

69 the risk for aerosol into 6 time-points: (1) intubation and extubation; (2) Lung isolation and patien

70 19 independently correlates with the risk of intubation and in-hospital mortality.

71 ad was independently associated with risk of intubation and in-hospital mortality.

72 he patients were hospitalized, 26% underwent intubation and mechanical ventilation, and two deaths we

73 citation and 214 (53.2%) had chosen to limit intubation and mechanical ventilation.Code status discus

74 and there was no association between time to intubation and mortality in adjusted analysis.

75 d seizures and acute renal failure requiring intubation and plasma exchange in the intensive care set

76 he first-attempt success rate of orotracheal intubation and reduces the risk of complications when co

77 known about the association between tracheal intubation and survival in this setting.

78 We examined the impact of time to intubation and use of high-flow nasal cannula on clinica

79 procedures (AOR = 1.5, p < 0.001), including intubation and ventilation (AOR = 2.4, p < 0.001); and o

80 morbidity (intensive care unit admission and intubation) and mortality outcomes between patients with

81 for admission, 0.66 (95% CI: 0.56, 0.75) for intubation, and 0.59 (95% CI: 0.49, 0.69) for death.

82 re Assessment for the first 7 days following intubation, and 4) change in Sequential Organ Failure As

83 l unit, resuscitation requiring drugs and/or intubation, and an Apgar score < 7 at 5 minutes (7.99%,

84 etween ABO and Rh blood types and infection, intubation, and death.

85 We also assessed the rates of ventilation, intubation, and dialysis, and looked for potential error

86 amined the association of AC with mortality, intubation, and major bleeding.

87 ive care unit involving respiratory failure, intubation, and mechanical ventilation.

88 ity, all-cause hospital admissions, need for intubation, and quality of life at the longest follow-up

89 ge, body mass index, diabetes, hypertension, intubation, and RRT.

90 ariables, and outcomes, including admission, intubation, and survival, were collected within 30 days

91 hospital admissions, 25% ICU admissions, 23% intubations, and 13% deaths.

92 ence interval [CI]: 2.92-12.52; P<0.001) and intubation (aOR 2.73; 95% CI: 1.68-4.44; P<0.001) in mul

93 OPH conjugated with pCB delivered through intubation-assisted intratracheal instillation (IAIS) in

94 lure was not associated with severe tracheal intubation-associated events (5% vs 5% without noninvasi

95 Severe tracheal intubation-associated events (cardiac arrest, esophageal

96 s the occurrence of either specific tracheal intubation-associated events (hemodynamic tracheal intub

97 ndependently associated with severe tracheal intubation-associated events (p = 0.35) or severe desatu

98 ell as its association with adverse tracheal intubation-associated events and oxygen desaturation in

99 failure was associated with severe tracheal intubation-associated events and severe oxygen desaturat

100 Specific tracheal intubation-associated events or oxygen desaturation even

101 ndependently associated with severe tracheal intubation-associated events or severe oxygen desaturati

102 tion-associated events (hemodynamic tracheal intubation-associated events, emesis with/without aspira

103 (>= 70%) was associated with severe tracheal intubation-associated events.

104 pies with adequate bowel cleansing and cecum intubation at 132 centers in the Polish National Colorec

105 goscope in the ICU on the first endotracheal intubation attempt and intubation-related complications

106 tive of this study was to evaluate the first intubation attempt success rate in the ICU with the McGr

107 the device following a failed first tracheal intubation attempt was more successful than a second att

108 After a failed first tracheal intubation attempt, immediate switching of the device wa

109 orithm, comprising a maximum of two tracheal intubation attempts with each device, followed by suprag

110 mortality, all-cause hospital admission, and intubation, but no significant difference in quality of

111 n the intensive care unit (ICU), orotracheal intubation can be associated with increased risk of comp

112 Tracheal intubation can be avoided by the start of the NPPV.

113 re Assessment for the first 7 days following intubation, change in Sequential Organ Failure Assessmen

114 equency of successful first-pass orotracheal intubation compared with direct laryngoscopy in ICU pati

115 determine whether ketamine use for tracheal intubation, compared to other sedative use, is associate

116 Secondary outcomes included peri-intubation complications, apneic time, PaO2 before and a

117 ation may not provide any benefit over cecal intubation concerning the detection of cADs and SPs in t

118 NIV were associated with subsequent need for intubation.Conclusions: As compared with HFNC in hypoxem

119 rtion of patients with successful first-pass intubation did not differ significantly between the vide

120 Certain exposures (such as involvement in intubations, direct patient contact, or contact with bod

121 To determine whether tracheal intubation during adult in-hospital cardiac arrest is as

122 Tracheal intubation during cardiac arrest.

123 ng delayed cord clamping, stabilisation with intubation, early enteral feeding and caffeine administr

124 The study included 956 tracheal intubation encounters; 424 tracheal intubations (44%) oc

125 outcome was the rate of successful tracheal intubation; equivalence range was +/- 6.5% of success ra

126 s were randomly assigned to undergo tracheal intubation facilitated by rocuronium (n = 624) or succin

127 n surgical airway access in case of tracheal intubation failure.

128 y included patients less than 72 hours after intubation following informed consent from their next of

129 these findings do not support early tracheal intubation for adult in-hospital cardiac arrest.

130 DRs did not differ between ileal and cecal intubation for endoscopists with ADR >=25 and < 25%, res

131 randomized controlled trial, Sedation versus Intubation for Endovascular Stroke Treatment (SIESTA).

132 nicians, raises the probability of difficult intubation from 10% to greater than 60% for the average-

133 Primary tracheal intubation group included children without exposure to n

134 n failure group, higher FIO2 before tracheal intubation (>= 70%) was associated with severe tracheal

135 Patients requiring preimplant intubation had higher rates of postimplant complications

136 fter multivariable analysis, both preimplant intubation (hazard ratio, 1.20 [95% CI, 1.03-1.41]; P=0.

137 s ratio, 0.83; 95% CI, 0.58-1.17) or rate of intubation (high-flow nasal cannulae, 119/1,207 [9.9%] v

138 re Assessment for the first 7 days following intubation, highest Sequential Organ Failure Assessment

139 ntilation is commonly used prior to tracheal intubation; however, the epidemiology, risk factors, and

140 .01-1.10; p = 0.015), time from admission to intubation (hr) (unit odds ratio, 1.01; 1.01-1.03; p = 0

141 also had a significantly lower risk of post-intubation hypotension (OR 0.47 [95% CI, 0.31-0.71] P <

142 The ketamine group had a lower risk of post-intubation hypotension compared to the reference group (

143 use, is associated with a lower risk of post-intubation hypotension in hemodynamically-unstable patie

144 The primary outcome was post-intubation hypotension.

145 Overall, 24% of patients developed post-intubation hypotension.

146 had no effect on the occurrence rate of peri-intubation hypoxemia (relative risk, 0.98; 95% CI, 0.68-

147 aO2 before and after intubation, PaCO2 after intubation, ICU length of stay, and short-term mortality

148 rt- and long-term consequences, including re-intubations, ICU readmissions, prolonged ICU and hospita

149 succinylcholine (1 mg/kg) for rapid sequence intubation in 1248 adult patients needing out-of-hospita

150 2% cases, with respiratory failure requiring intubation in 29%, and the mortality rate was 32%.

151 ) and serrated polyps (SP) compared to cecal intubation in a large screening colonoscopy cohort.

152 se paralytic agents for achieving successful intubation in an emergency setting has not been evaluate

153 Among patients undergoing endotracheal intubation in an out-of-hospital emergency setting, rocu

154 With the exception of endotracheal intubation in children, secondary safety outcomes did no

155 ventilation is widely used to avoid tracheal intubation in critically ill children.

156 s often performed for prolonged endotracheal intubation in critically ill patients.

157 timal preoxygenation method for endotracheal intubation in critically ill patients.

158 rt ketamine use as a safe sedative agent for intubation in hemodynamically-unstable patients in the E

159 preventive strategies such as preprocedural intubation in high risk patients when PPCI is the prefer

160 d to be as effective as 8-week bicanalicular intubation in improving anatomical outcome after MMED fo

161 airways abnormalities requiring orotracheal intubation in operating theatres at four quaternary chil

162 All patients undergoing tracheal intubation in participating sites were included.

163 a clinical study analyzing capnograms after intubation in patients with out-of-hospital cardiac arre

164 Tracheal intubation in prehospital emergency care is challenging.

165 was NIV failure (intubation or death without intubation in the ICU).

166 icantly higher after ileal compared to cecal intubation in univariate (12.5% vs. 6.8%, p < 0.001, and

167 Consecutive endotracheal intubations in critically ill patients.

168 -reported aspiration occurred during 2.5% of intubations in the bag-mask ventilation group and during

169 ting an advanced airway such as endotracheal intubation) in patients with out-of-hospital cardiac arr

170 ion findings that best predicted a difficult intubation included a grade of class 3 on the upper lip

171 atory Support profile 1 patients, preimplant intubation incurred additional risk of death at 1 year c

172 No restrictions were given for tracheal intubation indication.

173 was a composite adverse clinical outcome of intubation, intensive care unit admission, or death.

174 imated and inadequate documentation of cecal intubation is associated with a lower polyp detection ra

175 Tracheal intubation is common during adult in-hospital cardiac ar

176 Tracheal intubation is common in the care of critically ill adult

177 Tracheal intubation is commonly performed in critically ill patie

178 Recognizing patients in whom endotracheal intubation is likely to be difficult can help alert phys

179 of high-flow nasal cannula during and before intubation is unclear despite a number of randomized cli

180 ference in hospital length of stay, need for intubation, length of intubation, tracheostomy tube plac

181 Mortality did not differ by time to intubation (<= 8 hr: 38.2%; 8-24 hr: 31.6%; >= 24 hr: 38

182 We aimed to investigate if ileal intubation may be associated with higher detection rates

183 eterminants of hypoxemia during endotracheal intubation may be related to critical illness severity a

184 Ileal intubation may not provide any benefit over cecal intuba

185 o 10.7 mm Hg higher), or PaO2 measured after intubation (mean difference, 27.0 mm Hg higher; 95% CI,

186 healthy volunteers by use of the naso-ileal intubation method, which allows continuous collection of

187 had the best prognostic accuracy for 30-day intubation/mortality (area under the receiver-operating

188 in the ED have good predictive accuracy for intubation/mortality and oxygen requirement.

189 espiratory rate and sTREM-1 predicted 30-day intubation/mortality with 94% sensitivity and 0.1 negati

190 ns and these biomarkers in predicting 30-day intubation/mortality, and oxygen requirement by calculat

191 compared with those who needed endotracheal intubation (n = 12) (median [interquartile range], 11 [8

192 of 3 or more was an independent predictor of intubation (n = 28) (odds ratio, 4.7; 95% CI: 1.8, 13; P

193 he implantation procedure (aspiration during intubation, nausea and vomiting, and venous injury or co

194 Nasogastric intubation (NGI) is usually challenging in patients unde

195 higher likelihood of difficult endotracheal intubation, no clinical finding reliably excludes a diff

196 ase 2019, neither time from ICU admission to intubation nor high-flow nasal cannula use were associat

197 nnula oxygen use was neither associated with intubation nor mortality rates.

198 Numerically more episodes of hypotension and intubation occurred in the fosphenytoin group and more d

199 Fewer oesophageal intubations occurred in the video laryngoscopy group (n=

200 FA score was associated with higher odds for intubation (odds ratio = 1.6, 95% confidence interval =

201 ed for use in prehospital emergency tracheal intubation of adult patients.

202 the most common complication during tracheal intubation of critically ill adults and may increase the

203 e of cardiovascular collapse during tracheal intubation of critically ill adults compared with no flu

204 evice (bag-mask ventilation) during tracheal intubation of critically ill adults prevents hypoxemia w

205 us to prevent cardiovascular collapse during intubation of critically ill adults.

206 Orotracheal intubation of infants using direct laryngoscopy can be c

207 ds of the canaliculus allowing silicone tube intubation of the lacrimal system.

208 rdiopulmonary resuscitation, or endotracheal intubation on the day of the IR procedure.

209 associated with a 2.3-fold increased risk of intubation or death (95% CI, 1.2-4.3) compared with indi

210 associated with a 4.5-fold increased risk of intubation or death (95% CI, 2.0-10.2) compared with pat

211 sociation between hydroxychloroquine use and intubation or death (hazard ratio, 1.04, 95% confidence

212 s also independently associated with risk of intubation or death (hazard ratio, 1.8; 95% CI, 1.2-2.7)

213 sociation between hydroxychloroquine use and intubation or death at a large medical center in New Yor

214 nts and found that severe cases resulting in intubation or death exhibited increased inflammatory mar

215 besity is associated with increased risk for intubation or death from COVID-19 in adults younger than

216 The primary end point was a composite of intubation or death in a time-to-event analysis.

217 Tocilizumab was not effective for preventing intubation or death in moderately ill hospitalized patie

218 The hazard ratio for intubation or death in the tocilizumab group as compared

219 The primary end point was a composite of intubation or death in time-to-event analysis.

220 association between PXS score and subsequent intubation or death was assessed.

221 sion CXR, the PXS score predicted subsequent intubation or death within three days of hospital admiss

222 The primary endpoint was NIV failure (intubation or death without intubation in the ICU).

223 nd severe disease (defined as ICU admission, intubation or death).

224 The primary outcome was intubation or death, assessed in a time-to-event analysi

225 s, patients with obesity had higher risk for intubation or death, with the highest risk among those w

226 , obesity was an independent risk factor for intubation or death.

227 increased risk of the composite end point of intubation or death.

228 track disease change and predict subsequent intubation or death.

229 The primary endpoint was a composite of intubation or death.

230 compared with standard oxygen did not reduce intubation or survival rates.

231 bilateral infiltrates, either on the day of intubation or within the following 2 days, were compared

232 =25% was significantly associated with ileal intubation (OR 21.862, 95%-CI 18.049-26.481, p < 0.001).

233 y disease (OR, 0.53) and invasive mechanical intubation (OR, 0.43) were associated with a decreased r

234 e risk of SAOs (adjudicated hospitalization, intubation, or death) compared with mometasone furoate a

235 t between induction and 2 min after tracheal intubation; or cardiac arrest or death within 1 h of tra

236 PO-DNA complexes increased in COVID-19, with intubation (P < .0001) and death (P < .0005) as outcome.

237 nous thrombosis had no difference in time to intubation (p = 0.97) but underwent ultrasound earlier i

238 ications, apneic time, PaO2 before and after intubation, PaCO2 after intubation, ICU length of stay,

239 ng critically ill adults undergoing tracheal intubation, patients receiving bag-mask ventilation had

240 The proportion of first-attempt intubations performed by nonexperts (primarily residents

241 y, or overall survival when used in the peri-intubation period when compared with conventional oxygen

242 efits of high-flow nasal cannula in the peri-intubation period.

243 espiratory diagnosis/indication for tracheal intubation, presence of difficult airway features, more

244 tcomes of interest included hospitalization, intubation, prolonged stay, sepsis, and death.

245 High cecal intubation rate (CIR) is associated with significant imp

246 l oxygen was neither associated with a lower intubation rate (hazard ratio, 0.42; 95% CI, 0.11-1.61;

247 = 0.0002) were independently associated with intubation rate.

248 scopy did not improve first-pass orotracheal intubation rates and was associated with higher rates of

249 The most common intubation-related adverse events were hypoxemia (55 of

250 he first endotracheal intubation attempt and intubation-related complications is controversial.

251 Severe hypoxemia and overall immediate intubation-related complications occurred more frequentl

252 cribe its association with the occurrence of intubation-related complications.

253 r imaging utilization, hospitalizations, ICU/intubation requirement, longer hospital stays, and >4-fo

254 otension or cardiac arrhythmia, endotracheal intubation, seizure recurrence, and death.

255 lt non-cardiac-arrest ED patients with a pre-intubation shock index of >=0.9.

256 Maximal IL-6 level before intubation showed the strongest association with the nee

257 The primary outcome was the intubation success rate on first attempt.

258 noninferiority with regard to first-attempt intubation success rate.

259 d, is an independent factor of first-attempt intubation success.

260 Awake bronchoscopic intubation supported with a noninvasive positive pressur

261 ovel technique combining awake bronchoscopic intubation supported with nasally delivered noninvasive

262 er system, 2) bolus administration using the Intubation Surfactant Extubation method (200 mg/kg), or

263 d poractant alfa compared with that with the intubation surfactant extubation technique or continuous

264 lation, supraglottic airway, or endotracheal intubation), the training and retraining required, the a

265 oped focused on clinical decisions regarding intubation, the use of high-flow oxygen, engagement with

266 Levels were correlated with PGD severity and intubation time.

267 he number of attempts to successful tracheal intubation, time to glottis passage and first end-tidal

268 gnificant difference with regard to tracheal intubation times, number of attempts or difficulty.

269 in Sequential Organ Failure Assessment from intubation to 7 days later, and calorie delivery the fir

270 in Sequential Organ Failure Assessment from intubation to 7 days later.

271 re randomized within the first 24 hours from intubation to either nonsedation with sufficient analges

272 randomly assigned adults undergoing tracheal intubation to receive either ventilation with a bag-mask

273 heostomy, the average time from endotracheal intubation to tracheostomy was 19.7 days +/- 6.9 days.

274 ngth of stay, need for intubation, length of intubation, tracheostomy tube placement, hospital readmi

275 seven [4%] vs two [1%], death within 1 h of intubation two [1%] vs one [1%]).

276 A secondary outcome was endotracheal intubation up to 30 days.

277 Among patients in the ICU requiring intubation, video laryngoscopy compared with direct lary

278 t radiography in the 48 hours after tracheal intubation was 16.4% and 14.8%, respectively (P = 0.73).

279 The median time to successful intubation was 3 minutes (range, 2 to 4 minutes) for bot

280 er of patients with successful first-attempt intubation was 455 of 610 (74.6%) in the rocuronium grou

281 The risk of intubation was also higher in patients with a high viral

282 Risk of intubation was decreased among A and increased among AB

283 The risk of bias due to lack of blinding for intubation was deemed high.

284 s existed in prespecified subgroup analyses, intubation was not associated with improved outcomes in

285 High-flow nasal cannula use prior to intubation was not associated with mortality.

286 mal pulse oximetry value during endotracheal intubation was the primary endpoint.

287 advanced care such as drugs and endotracheal intubation) was collected.

288 calorie delivery the first 7 days following intubation were all associated with increased likelihood

289 proportion of patients requiring preimplant intubation were Interagency Registry for Mechanically As

290 ill adults (>=18 years) undergoing tracheal intubation were randomly assigned (1:1, block sizes of 2

291 clinical findings for identifying difficult intubation were reviewed.

292 jor interventions (vasopressor medication or intubation) were required for 29 of 119 (24%) patients,

293 critically ill adults requiring endotracheal intubation who were included in the MACMAN trial.

294 spiratory failure who underwent endotracheal intubation with a novel technique combining awake bronch

295 ,501) of 15,810 patients undergoing tracheal intubation with bag-mask ventilation during the study pe

296 ssociated events (cardiac arrest, esophageal intubation with delayed recognition, emesis with aspirat

297 exposure was ketamine use as a sedative for intubation, with midazolam or propofol use as the refere

298 AD placement, 906 (5.5%) required preimplant intubation within 48 hours before implantation, and 1001

299 ore experienced provider level, and tracheal intubations without use of neuromuscular blockade (p < 0

300 nized complication of prolonged endotracheal intubation, yet little attention has been paid to the co